# iShares Biotechnology ETF (IBB): ETF Facts & Distributions > Markdown mirror of https://www.dividenddata.com/funds/ibb for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice. - Issuer: IShares · Asset class: Equity - Strategy: Thematic · Inception: 2001-02-05 The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector. ## Key Facts | Metric | Value | |---|---| | Price | $207.74 | | Expense Ratio | 0.44% | | Assets Under Management | $10.91B | | NAV | $209.58 | | Holdings Count | 243 | | Distribution Yield (TTM) | 0.16% | | Annual Distribution (TTM) | $0.34 /share | | Distribution Frequency | Quarterly | | 52-Week Range | $154.62 – $217.12 | | Beta | 0.70 | ## Latest Distribution - Amount: $0.0112 /share - Ex-date: 2026-09-15 - Pay date: 2026-09-18 ## Frequently Asked Questions ### What does IBB invest in? The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector. ### What is the expense ratio of IBB? iShares Biotechnology ETF (IBB) charges an expense ratio of 0.44%. This is the annual fee deducted from fund assets to cover management and operations. ### How big is IBB? iShares Biotechnology ETF (IBB) manages $10.91B in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation. ### Is IBB actively managed or an index fund? IBB's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy. ### When was IBB launched? iShares Biotechnology ETF (IBB) launched in February 2001 and is managed by IShares. ### How has IBB performed? IBB's total return (price change plus reinvested distributions) is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon. ### Does IBB pay a dividend? iShares Biotechnology ETF (IBB) currently distributes little or no income. Trailing-twelve-month yield is 0.16%. Investors looking for income should consider income-focused alternatives. See the Peers tab. ### How often does IBB pay dividends? iShares Biotechnology ETF pays dividends Quarterly. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page. ### What is IBB's dividend yield? IBB's trailing-twelve-month yield is 0.16%, calculated from the sum of dividends over the past year divided by the current price. ### When is IBB's next ex-dividend date? The most recently announced ex-dividend date for IBB was 2026-09-15. The next ex-date typically follows Quarterly; once announced it appears at the top of the dividend history table on this page. ### How much will IBB's expense ratio cost me over 30 years? On a $10,000 investment compounding at 7% gross return, a 0.44% expense ratio quietly compounds against your balance every year. The Fee Compounding Forecast card above projects the dollar drag for any holding period and assumption you pick. The typical result for a 1.0% expense ratio on a 30-year hold is roughly 25% of the final balance lost to fees. ### How does IBB charge its expense ratio? The expense ratio is deducted in tiny daily slices from IBB's net asset value (NAV). You never see a bill. The price quoted on every exchange is already net of fees. There's no "fee day" to avoid; the cost is continuous and built into the trading price. ### Why does IBB cost more than a fund like VOO? IBB's strategy (current expense ratio 0.44%) is different from a broad-market index tracker like VOO, so its fee belongs to a different cohort. The Cost Verdict card above shows you where IBB sits within its own category, which is the comparison that actually matters. ### Are there cheaper alternatives to IBB? The Lower-Fee Alternatives card above lists ETFs following the same investment strategy as IBB (0.44%) but at a lower expense ratio. Each row shows the fee gap, the peer's AUM as a liquidity sanity-check, and a direct link to that fund's analysis page. Cheaper price doesn't automatically mean better. Verify the peer holds what you actually want. ## More on Dividend Data - Overview (HTML): https://www.dividenddata.com/funds/ibb - Distribution history: https://www.dividenddata.com/funds/ibb/dividend - Holdings & diversification: https://www.dividenddata.com/funds/ibb/diversification - Fees & cheaper alternatives: https://www.dividenddata.com/funds/ibb/expenses - Peer comparison: https://www.dividenddata.com/funds/ibb/peers Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.